Markets

Tuesday 12/22 Insider Buying Report: SNSS, HCAP

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

On Monday, Sunesis Pharmaceuticals ( SNSS )'s Director, Dayton Misfeldt, made a $1.47M buy of SNSS, purchasing 1,750,000 shares at a cost of $0.84 a piece. So far Misfeldt is in the green, up about 15.4% on their buy based on today's trading high of $0.97. Sunesis Pharmaceuticals is trading up about 8.9% on the day Tuesday. This buy marks the first one filed by Misfeldt in the past twelve months.

And on Friday, Director Joseph A. Jolson purchased $364,456 worth of Harvest Capital Credit ( HCAP ), purchasing 32,407 shares at a cost of $11.25 a piece. Before this latest buy, Jolson purchased HCAP at 3 other times during the past twelve months, for a total cost of $441,424 at an average of $11.74 per share. Harvest Capital Credit is trading up about 3% on the day Tuesday.

VIDEO: Tuesday 12/22 Insider Buying Report: SNSS, HCAP

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

SNSS HCAP

Other Topics

Investing

Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More